Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interleukin-15 and cancer: some solved and many unsolved questions
Piera Filomena Fiore, Sabina Di Matteo, Nicola Tumino, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001428-e001428
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy
Kaiyuan Wang, Xuanbo Zhang, Hao Ye, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review
Toufik Abdul‐Rahman, Shankhaneel Ghosh, Sarah M. Badar, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 31
Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
Cai Zhang, Yuan Hu, Weihua Xiao, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 9, pp. 2083-2100
Open Access | Times Cited: 69
Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity
Jingya Guo, Yong Liang, Diyuan Xue, et al.
Cell Research (2021) Vol. 31, Iss. 11, pp. 1190-1198
Open Access | Times Cited: 61
Interleukin 15 in Cell-Based Cancer Immunotherapy
Yang Zhou, Tiffany Husman, Xinjian Cen, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7311-7311
Open Access | Times Cited: 61
piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells
Zhicheng Du, Yu Yang Ng, Shijun Zha, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 582-596
Open Access | Times Cited: 58
Research progress of interleukin-15 in cancer immunotherapy
Menghan Cai, Xuan Huang, Xiting Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 41
The application of Interleukin-2 family cytokines in tumor immunotherapy research
Yangyihua Zhou, Guiqi Quan, Yujun Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Crosstalk between macrophages and natural killer cells in the tumor microenvironment
Jingping Zhou, Shaolong Zhang, Changying Guo
International Immunopharmacology (2021) Vol. 101, pp. 108374-108374
Closed Access | Times Cited: 46
Enhanced development of functional human NK cells in NOD‐scid‐IL2rgnull mice expressing human IL15
Ken‐Edwin Aryee, Lisa Burzenski, Li‐Chin Yao, et al.
The FASEB Journal (2022) Vol. 36, Iss. 9
Open Access | Times Cited: 32
Exercise-induced IL-15 acted as a positive prognostic implication and tumor-suppressed role in pan-cancer
Zhiwen Luo, Zhong He, Haocheng Qin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 29
The role of interleukin-15 in the development and treatment of hematological malignancies
Paola Del Sindaco, Hritisha Pandey, Colleen Isabelle, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation
Junghwa Lee, Kyung‐Min Lee, Hyeonjin Bae, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 20
IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside
Sogand Vahidi, Arefeh Zabeti Touchaei, Ali Akbar Samadani
International Immunopharmacology (2024) Vol. 133, pp. 112156-112156
Closed Access | Times Cited: 7
Role of m6A modifications in immune evasion and immunotherapy
Chunyu Wu, Lvyuan Li, Qiling Tang, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 6
A very long-acting IL-15: implications for the immunotherapy of cancer
John A. Hangasky, Wei Chen, Sigrid Dubois, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e004104-e004104
Open Access | Times Cited: 27
An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery
Jiao Shen, Zhuangzhi Zou, Jingya Guo, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 12
Open Access | Times Cited: 24
Lung cancer cell-intrinsic IL-15 promotes cell migration and sensitizes murine lung tumors to anti-PD-L1 therapy
Shaojie Hu, Kelin Meng, Tianlai Wang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells
Fang Zhang, Xinyi Ding, Hao Huang, et al.
Cancer Biology and Medicine (2024), pp. 1-14
Open Access | Times Cited: 5
The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity
Nicola Tumino, Carina B. Nava Lauson, Silvia Tiberti, et al.
International Journal of Cancer (2022) Vol. 152, Iss. 8, pp. 1698-1706
Open Access | Times Cited: 21
Disruption of H3K36 methylation provokes cellular plasticity to drive aberrant glandular formation and squamous carcinogenesis
Eun Kyung Ko, Amy Anderson, C. D'souza, et al.
Developmental Cell (2024) Vol. 59, Iss. 2, pp. 187-198.e7
Closed Access | Times Cited: 4
Exploring Cytokines Dynamics: Uncovering Therapeutic Concepts for Metabolic Disorders in Postmenopausal Women- Diabetes, Metabolic Bone Diseases, and Non-Alcohol Fatty Liver Disease
Amin Ullah, Yongxiu Chen, Rajeev K. Singla, et al.
Ageing Research Reviews (2024), pp. 102505-102505
Closed Access | Times Cited: 4
Regulation of NK cell development, maturation, and antitumor responses by the nuclear receptor NR2F6
Johannes Woelk, Florian Hornsteiner, Stephanie Aschauer-Wallner, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Zhen-Wu-Tang ameliorates lupus nephritis by diminishing renal tissue-resident memory CD8+ T cells via suppressing IL-15/STAT3 pathway
Chun-Ling Liang, Yu-Yan Wei, Yi Chen, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116597-116597
Open Access | Times Cited: 3
Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers
Stéphane Champiat, Elena Garralda, Vladimir Galvao, et al.
Cell Reports Medicine (2025), pp. 101967-101967
Open Access
Page 1 - Next Page

Scroll to top